1. Introduction {#sec1}
===============

Autoimmune thyroid disease (AITD), mainly including Graves\' disease (GD) and Hashimoto\'s thyroiditis (HT), is an organ-specific autoimmune disease and affects up to 5% of the general population \[[@B1], [@B2]\]. Although the pathogenesis of AITD is still unknown, it is generally acknowledged that environmental factors and the intrinsic genetic predisposition of an individual play critical roles in the occurrence of the disease \[[@B3]\]. Environmental factors, such as viral infections, irradiation, drugs, and iodine intake, may involve interference with thyroid function, direct toxic effects on thyrocytes, immune stimulation, or other immunomodulatory effects \[[@B3], [@B4]\]. However, it is difficult to directly link an environmental exposure with AITD due to the intervention of genetic factors. Increasing evidence suggests that single-nucleotide polymorphisms (SNPs) in AITD-related genes can influence individual predisposition to the disease \[[@B5]--[@B7]\].

Vitamin D is a fat-soluble vitamin and is activated in the liver and kidney \[[@B8]\]. Activated vitamin D \[1,25(OH)~2~D\] can promote the differentiation of monocytes and inhibit the maturation of dendritic cells \[[@B9]\]. Furthermore, it can also suppress the production of cytokines, such as interleukin-1, interleukin-2, interleukin-6, and tumor necrosis factor \[[@B10]\]. These cytokines play important roles in the development of lymphocytes, which are believed to be involved in the pathogenesis of autoimmune diseases. The immunomodulatory actions of 1,25(OH)~2~D are mediated by its binding to vitamin D receptor (VDR), which belongs to the family of *trans*-acting transcriptional regulatory factors and is widely expressed in various immune cell subsets, including lymphocytes, macrophages, and several endocrine cells \[[@B11]\]. The gene encoding VDR contains 14 exons and spans approximately 75 kilobases on chromosome 12q13.11. Many SNPs have been identified in the *VDR* gene \[[@B12]\]. Among them, the association of *VDR* rs731236, rs1544410, rs2228570, and rs7975232 polymorphisms with AITD risk has been widely reported \[[@B13]--[@B34]\]. However, the results are inconsistent and ambiguous. Furthermore, considering that a single-center pilot study with small sample sizes may possess low statistical power, we performed a meta-analysis of all eligible studies to obtain a more precise conclusion.

2. Methods {#sec2}
==========

2.1. Search Strategy {#sec2.1}
--------------------

All related articles were obtained by systematically searching PubMed, Embase, Google Scholar, and Chinese National Knowledge Infrastructure (CNKI). The search keywords were as follows: "vitamin D receptor OR VDR," "polymorphism OR genetic variation OR genetic variant," and "autoimmune thyroid disease OR AITD OR thyroid." There were no limitations on language and year of publication. The last search was updated on August 28, 2017. Furthermore, the references of all related articles were also retrieved to find other eligible studies.

2.2. Inclusion and Exclusion Criteria {#sec2.2}
-------------------------------------

All eligible studies must meet the following inclusion criteria: (a) case-control studies; (b) evaluation of the association between *VDR* polymorphisms (rs731236, rs1544410, rs2228570, and rs7975232) and AITD risk; and (c) available genotype/allele frequencies. In addition, the exclusion criteria were as follows: (a) letters, reviews, and case reports and (b) duplicate publication. If multiple studies had overlapping data, only those with complete data were included.

2.3. Data Extraction {#sec2.3}
--------------------

Two authors independently reviewed the related articles and extracted the following data: first author\'s name, year of publication, region, ethnicity, genotyping methods, the number of cases and controls, and genotype/allele frequency. Any disagreement was resolved by discussion with each other.

2.4. Statistical Analysis {#sec2.4}
-------------------------

Hardy-Weinberg equilibrium (HWE) in the control group of each study was calculated by chi-square goodness-of-fit test, and *P* ~HWE~ \< 0.05 was considered as a deviation from HWE. The strength of the association between *VDR* polymorphisms (rs731236, rs1544410, rs2228570, and rs7975232) and AITD risk was evaluated by the pooled odds ratios (ORs) with 95% confidence intervals (CIs). The significance of the pooled ORs was assessed by the *Z* test, and *P* ~*Z*~ \< 0.05 was considered statistically significant. The chi-square based *Q*-test was used to investigate the between-study heterogeneity. If *P* ~H~ \< 0.1 indicated the existence of between-study heterogeneity, the random-effect model was used to calculate the pooled ORs; otherwise, the fixed-effect model was applied for the analysis. A sensitivity analysis was conducted by omitting one study each time to estimate the stability of the result. Publication bias was determined by Begg\'s funnel plot and Egger\'s test. A symmetric funnel plot and *P* value of Egger\'s test more than 0.05 indicated the lack of publication bias. All statistical tests were performed using Review Manager 5.2 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen) and the STATA 12.0 software (Stata Corporation, College Station, TX).

3. Results {#sec3}
==========

3.1. Study Selection and Characteristics {#sec3.1}
----------------------------------------

The flowchart for identifying eligible studies is shown in [Figure 1](#fig1){ref-type="fig"}. A total of 139 articles were obtained through an initial search. After reviewing the titles and abstracts of these articles, we excluded 113 unrelated articles. The remaining articles were further checked by a full-text review. Finally, 22 articles met the inclusion criteria and were included in this meta-analysis. The main characteristics of all included articles are shown in Tables [1](#tab1){ref-type="table"} and [S1](#supplementary-material-1){ref-type="supplementary-material"}. A total of 24 studies from 22 articles assessed the association of *VDR* polymorphisms and AITD risk. Thereinto, there were 15 studies on rs731236, 18 studies on rs1544410, 15 studies on rs2228570, and 16 studies on rs7975232. All studies used polymerase chain reaction-restriction fragment length polymorphism (PCR--RFLP) method for genotyping except for Meng et al.\'s study.

3.2. Quantitative Synthesis {#sec3.2}
---------------------------

The association between *VDR* rs731236 polymorphism and AITD risk is shown in [Table 2](#tab2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}. In the overall analysis, a significant association was found in homozygote comparison and recessive models (CC versus TT: OR = 0.67, 95% CI: 0.48--0.93, *P* ~*Z*~ = 0.02; CC versus CT + TT: OR = 0.80, 95% CI: 0.66--0.95, *P* ~*Z*~ = 0.01). In the stratification analysis based on clinical types, a significant association of *VDR* rs731236 polymorphism with HT risk was found in the homozygote comparison model (CC versus TT: OR = 0.58, 95% CI: 0.40--0.85, *P* ~*Z*~ = 0.005). In the subgroup analysis by ethnicity, a significant association was found in Asian (CC versus TT: OR = 0.49, 95% CI: 0.28--0.86, *P* ~*Z*~ = 0.01) and African populations (CC versus TT: OR = 0.28, 95% CI: 0.10--0.80, *P* ~*Z*~ = 0.02; CT versus TT: OR = 0.34, 95% CI: 0.16--0.74, *P* ~*Z*~ = 0.007; CC + CT versus TT: OR = 0.33, 95% CI: 0.16--0.86, *P* ~*Z*~ = 0.003). The pooled analysis based on *P* ~HWE~ \> 0.05 showed a significant association in the allele comparison model (C versus T: OR = 0.82, 95% CI: 0.68--0.99, *P* ~*Z*~ = 0.04).

The association of *VDR* rs1544410 polymorphism with AITD risk is presented in [Table 3](#tab3){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}. No significant association was observed in the overall analysis and stratification analysis by clinical types. However, a subgroup analysis by ethnicity showed that *VDR* rs1544410 polymorphism was associated with a reduced risk of AITD in European (AA versus GG: OR = 0.60, 95% CI: 0.46--0.93, *P* ~*Z*~ = 0.02; AG versus GG: OR = 0.83, 95% CI: 0.71--0.97, *P* ~*Z*~ = 0.02; AA + AG versus GG: OR = 0.79, 95% CI: 0.68--0.91, *P* ~*Z*~ = 0.002; A versus G: OR = 0.82, 95% CI: 0.69--0.98, *P* ~*Z*~ = 0.02) and African (AA versus GG: OR = 0.18, 95% CI: 0.06--0.53, *P* ~*Z*~ = 0.002; AA + AG versus GG: OR = 0.42, 95% CI: 0.20--0.90, *P* ~*Z*~ = 0.02; AA versus AG + GG: OR = 0.26, 95% CI: 0.10--0.66, *P* ~*Z*~ = 0.005) populations and with an increased risk of AITD in Asian populations (AG versus GG: OR = 1.34, 95% CI: 1.08--1.67, *P* ~*Z*~ = 0.008; AA + AG versus GG: OR = 1.41, 95% CI: 1.05--1.90, *P* ~*Z*~ = 0.02; A versus G: OR = 1.41, 95% CI: 1.05--1.90, *P* ~*Z*~ = 0.02). The pooled analysis based on *P* ~HWE~ \> 0.05 showed that *VDR* rs1544410 polymorphism was associated with a reduced risk of AITD (AA versus GG: OR = 0.66, 95% CI: 0.45--0.98, *P* ~*Z*~ = 0.04).

The association between *VDR* rs2228570 polymorphism and AITD risk is shown in [Table 4](#tab4){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}. A significant association was observed in the overall analysis (CT versus CC: OR = 0.73, 95% CI: 0.56--0.95, *P* ~*Z*~ = 0.02; TT + CT versus CC: OR = 0.71, 95% CI: 0.54--0.93, *P* ~*Z*~ \< 0.001; T versus C: OR = 0.80, 95% CI: 0.68--0.95, *P* ~*Z*~ = 0.01). A further stratification analysis by clinical types showed a significant association in HT (T versus C: OR = 0.69, 95% CI: 0.50--0.97, *P* ~*Z*~ = 0.03) but not in GD. A subgroup analysis based on ethnicity showed a significant association in Asian populations (TT versus CC: OR = 0.63, 95% CI: 0.42--0.93, *P* ~*Z*~ = 0.02; TT + CT versus CC: OR = 0.65, 95% CI: 0.45--0.95, *P* ~*Z*~ = 0.02; TT versus CT + CC: OR = 0.72, 95% CI: 0.58--0.91, *P* ~*Z*~ = 0.005; T versus C: OR = 0.72, 95% CI: 0.56--0.92, *P* ~*Z*~ = 0.008), but not in European populations. A stratification analysis by *P* ~HWE~ value showed a significant association in studies of *P* ~H~ ≤ 0.05 (CT versus CC: OR = 0.48, 95% CI: 0.36--0.65, *P* ~*Z*~ \< 0.001; TT + CT versus CC: OR = 0.51, 95% CI: 0.38--0.68, *P* ~*Z*~ \< 0.001; T versus C: OR = 0.72, 95% CI: 0.55--0.93, *P* ~*Z*~ = 0.01) but not in studies of *P* ~H~ \> 0.05.

For *VDR* rs7975232 polymorphism, no significant association was observed in the overall analysis and stratification analysis by clinical types and *P* ~HWE~ ([Table 5](#tab5){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}). However, a stratification analysis by ethnicity showed that *VDR* rs7975232 polymorphism was associated with an increased risk of AITD in African populations (CC versus AA: OR = 5.84, 95% CI: 2.00--17.02, *P* ~*Z*~ = 0.001; CA versus AA: OR = 3.02, 95% CI: 1.33--6.87, *P* ~*Z*~ = 0.008; CC + CA versus AA: OR = 3.62, 95% CI: 1.65--7.93, *P* ~*Z*~ = 0.001; CC versus CA + AA: OR = 2.79, 95% CI: 1.12--6.95, *P* ~*Z*~ = 0.03; C versus A: OR = 2.29, 95% CI: 1.41--3.73, *P* ~*Z*~ \< 0.001).

3.3. Sensitivity Analysis and Publication Bias {#sec3.3}
----------------------------------------------

A sensitivity analysis showed that the pooled OR values were not substantially changed after one study deletion each time, which suggests that results of this meta-analysis were stable. As shown in [Figure 3](#fig3){ref-type="fig"}, the shape of funnel plots was symmetric. In addition, all *P* values of Egger\'s test were more than 0.05, indicating the lack of publication bias ([Table 6](#tab6){ref-type="table"}).

4. Discussion {#sec4}
=============

As an immune modulator, vitamin D is involved in the onset and development of AITD \[[@B35], [@B36]\]. Low levels of vitamin D have been demonstrated in patients with AITD \[[@B36]\]. Furthermore, vitamin D deficiency was correlated with the duration of HT, which led to an increase in thyroid volume and in antithyroid antibodies levels \[[@B36]\]. Vitamin D exerts its biological effects by binding to VDR and activating VDR-responsive genes \[[@B37]\]. VDR is an intracellular receptor belonging to the steroid/thyroid nuclear receptor family and expressed in human immune cells including macrophages, dendritic cells, and T and B lymphocytes \[[@B35]\]. Therefore, the abnormal function of VDR, which is attributable to *VDR* gene polymorphisms and altered transactivation, might affect the immunoregulatory and anti-inflammatory functions of vitamin D and correlate with the pathogenesis of AITD. Some studies demonstrated that genetic polymorphisms (rs731236, rs1544410, rs2228570, and rs7975232) in the *VDR* gene could affect the expression of VDR \[[@B38], [@B39]\]. For instance, Ogunkolade et al. found that rs2228570 in the coding region of *VDR* gene was associated with higher VDR mRNA copy numbers \[[@B38]\]. Uitterlinden et al. observed that rs731236, rs1544410, and rs7975232 in the 3′ untranslated region of the *VDR* gene could affect VDR gene expression by modulating mRNA stability \[[@B39]\]. In view of all this, these functional polymorphisms were speculated to be associated with AITD risk. Interestingly, some epidemiological studies confirmed the speculation and found significant association between these polymorphisms and AITD risk. For instance, Long et al. and Meng et al. observed that *VDR* rs7975232 polymorphism was significantly associated with GD risk in Chinese populations \[[@B14], [@B15]\]. Djurovic et al. found a significant association between *VDR* rs2228570 polymorphism and HT risk in Serbian populations \[[@B16]\]. Stefanić et al. found that *VDR* rs731236, rs7975232, and rs1544410 polymorphisms were associated with GD susceptibility in Eastern Croatian populations \[[@B28]\]. Yazici et al. observed that *VDR* rs731236 and rs2228570 polymorphisms were significantly associated with HT risk in a Turkish population \[[@B19]\]. However, other studies including genome-wide association study showed that these polymorphisms did not influence individual susceptibility to AITD \[[@B13], [@B18], [@B20], [@B23], [@B24], [@B40], [@B41]\]. These inconsistent results may be due to the fact that a single-center pilot study with small sample sizes has low statistical power to detect a true association or that the genetic background of different populations changes the effect of low-penetration polymorphisms on AITD risk. In 2013, Feng et al. tried to clarify the association by meta-analysis and found that *VDR* rs1544410 and rs731236 polymorphisms were significantly associated with a reduced risk of AITD, while *VDR* rs7975232 and rs2228570 polymorphisms were not associated with AITD risk \[[@B42]\]. Due to the limited number of related studies, subgroup analyses by clinical types were not conducted. Furthermore, results of recent studies were still inconsistent with that of previous meta-analysis \[[@B13], [@B15], [@B16]\]. Therefore, an updated analysis was performed by combining the recent studies. Results indicated that *VDR* rs731236 and rs2228570 polymorphisms were significantly associated with reduced risk of AITD. A further stratification analysis based on clinical types showed that *VDR* rs731236 and rs2228570 polymorphisms were associated only with reduced risk of HT. In a stratification analysis based on ethnicity, *VDR* rs731236 polymorphism was associated with a reduced risk of AITD in Asian and African populations but not in European populations. *VDR* rs2228570 polymorphism was associated with a reduced risk of AITD only in Asian populations. It was worthy to note that *VDR* rs1544410 polymorphism was associated with a reduced risk of AITD in European and African populations but has an increased risk of AITD in Asian populations. A stratification analysis by *P* ~HWE~ values showed that the significant association of *VDR* rs2228570 polymorphism with a reduced risk of AITD was observed only in studies with *P* ~HWE~ ≤ 0.05, which indicated that the effect of *VDR* rs2228570 polymorphism on AITD risk needed to be interpreted cautiously.

Heterogeneity was observed in the current meta-analysis. We tried to investigate the sources of heterogeneity by a stratification analysis based on clinical types, ethnicity, and HWE, but the investigation results were not satisfactory and could not provide a reasonable explanation for the sources of heterogeneity. In view of factors affecting vitamin D levels and methodological issues, heterogeneity may result from differences in economic and public health indexes among different countries, variations in environment and climate, age and gender mismatch in published studies, and variations in diagnostic criteria for GD/HT.

Although the current results showed the statistically significant associations of *VDR* polymorphisms with AITD risk, such associations had a small influence on the occurrence of AITD. In addition, several limitations impeding accurate assessment should be noted. Firstly, raw data such as gender, age, living style, and drug consumption could not be obtained from all included studies. Secondly, the number of studies was small in the subgroup analysis, especially in African populations. Last but not least, the present analysis did not consider the gene-gene and gene-environment interactions.

In conclusion, the present study suggested that *VDR* rs731236, rs1544410, rs2228570, and rs7975232 polymorphisms were significantly associated with AITD risk. However, more well-designed studies, especially studies on African populations, should be performed to verify the results.
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Table S1: genotype and allele frequency distributions of *VDR* polymorphisms in all included studies.

###### 

Click here for additional data file.

![The flowchart for identifying eligible studies.](IJE2018-2846943.001){#fig1}

![Forest plot of the association of *VDR* polymorphisms with AITD risk in homozygote comparison model.](IJE2018-2846943.002){#fig2}

![Funnel plot of the association of *VDR* polymorphisms with AITD risk in homozygote comparison model.](IJE2018-2846943.003){#fig3}

###### 

The main characteristics of all included articles.

  First author                Year of publication   Region                    Ethnicity   Cases               Controls   Genotyping method   Polymorphisms
  --------------------------- --------------------- ------------------------- ----------- ------------------- ---------- ------------------- -------------------------------------------
  Giovinazzo \[[@B13]\]       2016                  Italy                     European    100 HT              100        PCR--RFLP           rs731236, rs7975232, rs1544410
  Guleryuz \[[@B33]\]         2016                  Turkey                    Asian       136 HT              50         PCR--RFLP           rs731236, rs2228570
  Long \[[@B14]\]             2015                  China                     Asian       260 GD              221        PCR--RFLP           rs7975232
  Meng \[[@B15]\]             2015                  China                     Asian       417 GD and 250 HT   301        MALDI-TOF-MS        rs731236, rs7975232, rs2228570, rs1544410
  Djurovic \[[@B16]\]         2015                  Serbia                    European    44 HT               32         PCR--RFLP           rs731236, rs7975232, rs2228570
  Inoue \[[@B17]\]            2014                  Japan                     Asian       139 GD and 116 HT   76         PCR--RFLP           rs731236, rs7975232, rs2228570, rs1544410
  Yu \[[@B18]\]               2013                  China                     Asian       75 HT               80         PCR--RFLP           rs1544410
  Yazici \[[@B19]\]           2013                  Turkey                    Asian       111 HT              159        PCR--RFLP           rs731236, rs7975232, rs2228570, rs1544410
  El Gawad \[[@B34]\]         2012                  Egypt                     African     90 GD               55         PCR--RFLP           rs731236, rs7975232, rs1544410
  Hong \[[@B20]\]             2011                  China                     Asian       82 HT               80         PCR--RFLP           rs2228570
  Huo \[[@B21]\]              2010                  China                     Asian       120 GD and 115 HT   120        PCR--RFLP           rs1544410
  Horst-Sikorska \[[@B22]\]   2008                  Poland                    European    75 GD               163        PCR--RFLP           rs731236, rs7975232, rs2228570, rs1544410
  Maalej \[[@B23]\]           2008                  Tunisia                   African     100 AITD            100        PCR--RFLP           rs731236, rs2228570, rs1544410
  Jing \[[@B24]\]             2008                  China                     Asian       115 HT              120        PCR--RFLP           rs1544410
  Stefanić \[[@B25]\]         2008                  Croatia                   European    145 HT              145        PCR--RFLP           rs731236, rs7975232, rs1544410
  Chen \[[@B31]\]             2007                  Taiwan                    Asian       88 GD               90         PCR--RFLP           rs2228570
  Lin \[[@B26]\]              2006                  Taiwan                    Asian       109 HT              90         PCR--RFLP           rs2228570
  Ramos-Lopez \[[@B27]\]      2005                  Germany, Poland, Serbia   European    789 GD              823        PCR--RFLP           rs731236, rs7975232, rs2228570, rs1544410
  Stefanić \[[@B28]\]         2005                  Croatia                   European    110 GD              99         PCR--RFLP           rs731236, rs7975232, rs1544410
  Kang \[[@B29]\]             2005                  China                     Asian       102 GD              120        PCR--RFLP           rs7975232, rs1544410
  Collins \[[@B32]\]          2004                  United Kingdom            European    768 GD              864        PCR--RFLP           rs731236, rs7975232, rs2228570, rs1544410
  Ban \[[@B30]\]              2000                  Japan                     Asian       180 GD              195        PCR--RFLP           rs7975232, rs2228570, rs1544410

PCR--RFLP: polymerase chain reaction-restriction fragment length polymorphism; MALDI-TOF-MS: matrix-assisted laser desorption ionization-time of flight mass spectrometry.

###### 

The association between *VDR* rs731236 polymorphism and AITD risk.

  Comparison model                         Subgroup   The number of studies   Sample size (cases/controls)   *I* ^2^   *P* ~H~   Effect model              OR (95% CI)               *P* ~*Z*~
  ---------------------------------------- ---------- ----------------------- ------------------------------ --------- --------- ------------------------- ------------------------- -----------
  Homozygote comparison (CC versus TT)     AITD       14                      1930/1341                      54%       0.008     Random                    **0.67 \[0.48, 0.93\]**   0.02
  HT                                       7          625/579                 41%                            0.12      Fixed     **0.58 \[0.40, 0.85\]**   0.005                     
  GD                                       9          1305/1087               53%                            0.03      Random    0.71 \[0.49, 1.04\]       0.08                      
  European                                 9          930/891                 53%                            0.03      Random    0.75 \[0.54, 1.05\]       0.09                      
  Asian                                    4          942/424                 47%                            0.13      Fixed     **0.49 \[0.28, 0.86\]**   0.01                      
  African                                  1          58/26                   ---                            ---       ---       **0.28 \[0.10, 0.80\]**   0.02                      
  Heterozygote comparison (CT versus TT)   AITD       14                      2674/1949                      70%       \<0.001   Random                    0.82 \[0.64, 1.05\]       0.11
  HT                                       7          827/778                 72%                            0.002     Random    0.82 \[0.52, 1.29\]       0.38                      
  GD                                       9          1847/1546               65%                            0.004     Random    0.85 \[0.65, 1.11\]       0.22                      
  European                                 9          1471/1354               50%                            0.04      Random    0.97 \[0.84, 1.13\]       0.71                      
  Asian                                    4          1123/551                82%                            \<0.001   Random    0.69 \[0.35, 1.35\]       0.27                      
  African                                  1          80/44                   ---                            ---       ---       **0.34 \[0.16, 0.74\]**   0.007                     
  Dominant model (CC + CT versus TT)       AITD       14                      2950/2254                      75%       \<0.001   Random                    0.79 \[0.61, 1.02\]       0.07
  HT                                       7          895/861                 75%                            \<0.001   Random    0.81 \[0.51, 1.29\]       0.38                      
  GD                                       9          2055/1769               71%                            \<0.001   Random    0.81 \[0.61, 1.07\]       0.13                      
  European                                 9          1705/1615               62%                            0.007     Random    0.90 \[0.70, 1.15\]       0.39                      
  Asian                                    4          1155/584                84%                            \<0.001   Random    0.69 \[0.34, 1.37\]       0.29                      
  African                                  1          90/55                   ---                            ---       ---       **0.33 \[0.16, 0.68\]**   0.003                     
  Recessive model (CC versus CT + TT)      AITD       14                      2950/2254                      7%        0.37      Fixed                     **0.80 \[0.66, 0.95\]**   0.01
  HT                                       7          895/861                 0%                             0.44      Fixed     0.71 \[0.50, 1.01\]       0.06                      
  GD                                       9          2055/1769               6%                             0.38      Fixed     0.84 \[0.68, 1.03\]       0.09                      
  European                                 9          1705/1615               26%                            0.21      Fixed     0.83 \[0.68, 1.01\]       0.06                      
  Asian                                    4          1155/584                0%                             0.61      Fixed     0.67 \[0.39, 1.17\]       0.16                      
  African                                  1          90/55                   ---                            ---       ---       0.50 \[0.20, 1.27\]       0.14                      
  Allele comparison (C versus T)           AITD       15                      3050/2354                      73%       \<0.001   Random                    0.85 \[0.71, 1.02\]       0.09
  HT                                       7          895/861                 70%                            0.003     Random    0.85 \[0.61, 1.19\]       0.35                      
  GD                                       9          2055/1769               70%                            \<0.001   Random    0.83 \[0.68, 1.02\]       0.08                      
  European                                 9          1705/1615               66%                            0.003     Random    0.89 \[0.74, 1.07\]       0.21                      
  Asian                                    4          1155/584                79%                            0.003     Random    0.77 \[0.47, 1.26\]       0.30                      
  African                                  2          190/155                 92%                            \<0.001   Random    0.84 \[0.27, 2.54\]       0.75                      
  HWE \> 0.05                              14         2950/2254               72%                            \<0.001   Random    **0.82 \[0.68, 0.99\]**   0.04                      

*P* ~H~: *P* value of heterogeneity test; *P~Z~*: *P* value of *Z* test.

###### 

The association between *VDR* rs1544410 polymorphism and AITD risk.

  Comparison model                         Subgroup   The number of studies   Sample size (cases/controls)   *I* ^2^   *P* ~H~   Effect model              OR (95% CI)           *P* ~*Z*~
  ---------------------------------------- ---------- ----------------------- ------------------------------ --------- --------- ------------------------- --------------------- -----------
  Homozygote comparison (AA versus GG)     AITD       17                      2405/2032                      57%       0.002     Random                    0.74 \[0.53, 1.02\]   0.07
  HT                                       8          763/837                 34%                            0.15      Fixed     0.80 \[0.55, 1.16\]       0.24                  
  GD                                       12         1642/1631               68%                            \<0.001   Random    0.71 \[0.46, 1.09\]       0.11                  
  European                                 8          959/1076                65%                            0.005     Random    **0.60 \[0.46, 0.93\]**   0.02                  
  Asian                                    8          1400/928                0%                             0.47      Fixed     1.51 \[0.90, 2.55\]       0.12                  
  African                                  1          46/28                   ---                            ---       ---       **0.18 \[0.06, 0.53\]**   0.002                 
  *P* ~HWE~ \> 0.05                        13         1823/1539               62%                            0.001     Random    **0.66 \[0.45, 0.98\]**   0.04                  
  *P* ~HWE~ ≤ 0.05                         4          582/493                 28%                            0.24      Fixed     1.06 \[0.70, 1.61\]       0.79                  
  Heterozygote comparison (AG versus GG)   AITD       17                      3180/2788                      38%       0.05      Random                    0.99 \[0.84, 1.18\]   0.93
  HT                                       8          925/984                 0%                             0.63      Fixed     1.07 \[0.84, 1.36\]       0.61                  
  GD                                       12         2255/2285               60%                            0.004     Random    0.99 \[0.78, 1.25\]       0.94                  
  European                                 8          1432/1638               0%                             0.85      Fixed     **0.83 \[0.71, 0.97\]**   0.02                  
  Asian                                    8          1666/1110               22%                            0.25      Fixed     **1.34 \[1.08, 1.67\]**   0.008                 
  African                                  1          82/40                   ---                            ---       ---       0.56 \[0.25, 1.23\]       0.15                  
  *P* ~HWE~ \> 0.05                        13         2475/2103               22%                            0.22      Fixed     0.95 \[0.82, 1.08\]       0.42                  
  *P* ~HWE~ ≤ 0.05                         4          705/685                 71%                            0.01      Random    1.32 \[0.69, 2.54\]       0.41                  
  Dominant model (AA + AG versus GG)       AITD       17                      3636/3373                      61%       \<0.001   Random                    0.98 \[0.80, 1.20\]   0.82
  HT                                       8          1009/1089               25%                            0.23      Fixed     1.03 \[0.82, 1.29\]       0.82                  
  GD                                       12         2627/2769               73%                            \<0.001   Random    0.97 \[0.74, 1.27\]       0.81                  
  European                                 8          1835/2177               3%                             0.41      Fixed     **0.79 \[0.68, 0.91\]**   0.002                 
  Asian                                    8          1711/1141               44%                            0.09      Random    **1.41 \[1.05, 1.90\]**   0.02                  
  African                                  1          90/55                   ---                            ---       ---       **0.42 \[0.20, 0.90\]**   0.02                  
  *P* ~HWE~ \> 0.05                        13         2869/2593               56%                            0.008     Random    0.91 \[0.74, 1.12\]       0.38                  
  *P* ~HWE~ ≤ 0.05                         4          767/780                 77%                            0.004     Random    1.39 \[0.70, 2.76\]       0.34                  
  Recessive model (AA versus AG + GG)      AITD       17                      3636/3373                      58%       0.002     Random                    0.79 \[0.59, 1.06\]   0.11
  HT                                       8          1009/1089               35%                            0.15      Fixed     0.82 \[0.59, 1.13\]       0.22                  
  GD                                       12         2627/2769               67%                            \<0.001   Random    0.77 \[0.53, 1.12\]       0.17                  
  European                                 8          1835/2177               71%                            0.001     Random    0.74 \[0.53, 1.02\]       0.06                  
  Asian                                    8          1711/1141               0%                             0.57      Fixed     1.42 \[0.87, 2.33\]       0.16                  
  African                                  1          90/55                   ---                            ---       ---       **0.26 \[0.10, 0.66\]**   0.005                 
  *P* ~HWE~ \> 0.05                        13         2869/2593               63%                            0.001     Random    0.72 \[0.51, 1.01\]       0.05                  
  *P* ~HWE~ ≤ 0.05                         4          767/780                 8%                             0.35      Fixed     1.18 \[0.82, 1.72\]       0.37                  
  Allele comparison (A versus G)           AITD       18                      3736/3473                      72%       \<0.001   Random                    0.96 \[0.81, 1.13\]   0.63
  HT                                       8          1009/1089               58%                            0.02      Random    1.08 \[0.81, 1.44\]       0.60                  
  GD                                       12         2627/2769               80%                            \<0.001   Random    0.97 \[0.77, 1.21\]       0.76                  
  European                                 8          1835/2177               66%                            0.005     Random    **0.82 \[0.69, 0.98\]**   0.02                  
  Asian                                    8          1711/1141               58%                            0.02      Random    **1.41 \[1.05, 1.90\]**   0.02                  
  African                                  2          190/155                 72%                            0.06      Random    0.64 \[0.35, 1.15\]       0.14                  
  *P* ~HWE~ \> 0.05                        13         2969/2693               70%                            \<0.001   Random    0.89 \[0.75, 1.06\]       0.21                  
  *P* ~HWE~ ≤ 0.05                         4          767/780                 79%                            0.002     Random    1.44 \[0.78, 2.65\]       0.24                  

*P* ~H~: *P* value of heterogeneity test; *P~Z~*: *P* value of *Z* test.

###### 

The association between *VDR* rs2228570 polymorphism and AITD risk.

  Comparison model                         Subgroup   The number of studies   Sample size (cases/controls)   *I* ^2^   *P* ~H~   Effect model              OR (95% CI)               *P* ~*Z*~
  ---------------------------------------- ---------- ----------------------- ------------------------------ --------- --------- ------------------------- ------------------------- -----------
  Homozygote comparison (TT versus CC)     AITD       14                      1713/1474                      64%       \<0.001   Random                    0.76 \[0.55, 1.04\]       0.09
  HT                                       7          509/440                 27%                            0.22      Fixed     0.77 \[0.55, 1.07\]       0.11                      
  GD                                       9          1204/1224               73%                            \<0.001   Random    0.79 \[0.54, 1.15\]       0.22                      
  European                                 6          819/907                 72%                            0.003     Random    0.93 \[0.58, 1.49\]       0.76                      
  Asian                                    8          894/567                 45%                            0.08      Random    **0.63 \[0.42, 0.93\]**   0.02                      
  *P* ~HWE~ \> 0.05                        11         1409/1301               71%                            \<0.001   Random    0.78 \[0.53, 1.14\]       0.20                      
  *P* ~HWE~ ≤ 0.05                         3          304/173                 0%                             0.89      Fixed     0.65 \[0.42, 1.00\]       0.05                      
  Heterozygote comparison (CT versus CC)   AITD       14                      2478/2123                      72%       \<0.001   Random                    **0.73 \[0.56, 0.95\]**   0.02
  HT                                       7          665/600                 77%                            0.001     Random    0.61 \[0.35, 1.06\]       0.08                      
  GD                                       9          1813/1832               65%                            0.004     Random    0.83 \[0.64, 1.07\]       0.14                      
  European                                 6          1145/1315               77%                            \<0.001   Random    0.78 \[0.52, 1.16\]       0.22                      
  Asian                                    8          1333/808                70%                            0.001     Random    0.68 \[0.47, 1.00\]       0.05                      
  *P* ~HWE~ \> 0.05                        11         2008/1762               66%                            0.001     Random    0.84 \[0.64, 1.10\]       0.21                      
  *P* ~HWE~ ≤ 0.05                         3          470/361                 32%                            0.23      Fixed     **0.48 \[0.36, 0.65\]**   \<0.001                   
  Dominant model (TT + CT versus CC)       AITD       14                      3174/2836                      76%       \<0.001   Random                    **0.71 \[0.54, 0.93\]**   \<0.001
  HT                                       7          839/788                 77%                            \<0.001   Random    0.60 \[0.35, 1.02\]       0.06                      
  GD                                       9          2335/2425               72%                            \<0.001   Random    0.81 \[0.62, 1.06\]       0.12                      
  European                                 6          1562/1795               80%                            \<0.001   Random    0.78 \[0.52, 1.18\]       0.24                      
  Asian                                    8          1612/1041               72%                            \<0.001   Random    **0.65 \[0.45, 0.95\]**   0.02                      
  *P* ~HWE~ \> 0.05                        11         2616/2416               74%                            \<0.001   Random    0.81 \[0.60, 1.08\]       0.14                      
  *P* ~HWE~ ≤ 0.05                         3          558/420                 36%                            0.21      Fixed     **0.51 \[0.38, 0.68\]**   \<0.001                   
  Recessive model (TT versus CT + CC)      AITD       14                      3174/2836                      54%       0.008     Random                    0.87 \[0.68, 1.10\]       0.23
  HT                                       7          839/788                 0%                             0.46      Fixed     0.79 \[0.59, 1.06\]       0.11                      
  GD                                       9          2335/2425               64%                            0.004     Random    0.90 \[0.68, 1.19\]       0.46                      
  European                                 6          1562/1795               60%                            0.03      Random    1.05 \[0.76, 1.45\]       0.79                      
  Asian                                    8          1612/1041               23%                            0.24      Fixed     **0.72 \[0.58, 0.91\]**   0.005                     
  *P* ~HWE~ \> 0.05                        11         2616/2416               64%                            0.002     Random    0.83 \[0.62, 1.11\]       0.20                      
  *P* ~HWE~ ≤ 0.05                         3          558/420                 0%                             0.89      Fixed     1.02 \[0.71, 1.48\]       0.91                      
  Allele comparison (T versus C)           AITD       15                      3274/2936                      75%       \<0.001   Random                    **0.80 \[0.68, 0.95\]**   0.01
  HT                                       7          839/788                 72%                            0.001     Random    **0.69 \[0.50, 0.97\]**   0.03                      
  GD                                       9          2335/2425               76%                            \<0.001   Random    0.87 \[0.73, 1.05\]       0.15                      
  European                                 6          1562/1795               79%                            \<0.001   Random    0.90 \[0.70, 1.16\]       0.41                      
  Asian                                    8          1612/1041               69%                            0.002     Random    **0.72 \[0.56, 0.92\]**   0.008                     
  African                                  1          100/100                 ---                            ---       ---       0.86 \[0.53, 1.39\]       0.54                      
  *P* ~HWE~ \> 0.05                        11         2716/2516               77%                            \<0.001   Random    0.83 \[0.68, 1.01\]       0.06                      
  *P* ~HWE~ ≤ 0.05                         3          558/420                 38%                            0.20      Fixed     **0.72 \[0.55, 0.93\]**   0.01                      

*P* ~H~: *P* value of heterogeneity test; *P~Z~*: *P* value of *Z* test.

###### 

The association between *VDR* rs7975232 polymorphism and AITD risk.

  Comparison model                         Subgroup   The number of studies   Sample size (cases/controls)   *I* ^2^   *P* ~H~   Effect model               OR (95% CI)           *P* ~*Z*~
  ---------------------------------------- ---------- ----------------------- ------------------------------ --------- --------- -------------------------- --------------------- -----------
  Homozygote comparison (CC versus AA)     AITD       16                      1899/1606                      76%       \<0.001   Random                     1.16 \[0.84, 1.61\]   0.37
  HT                                       6          396/434                 33%                            0.19      Fixed     1.11 \[0.80, 1.55\]        0.52                  
  GD                                       12         1503/1403               81%                            \<0.001   Random    1.22 \[0.81, 1.83\]        0.34                  
  European                                 9          983/1016                71%                            \<0.001   Random    1.10 \[0.76, 1.60\]        0.62                  
  Asian                                    6          876/561                 80%                            \<0.001   Random    1.02 \[0.55, 1.92\]        0.94                  
  African                                  1          40/29                   ---                            ---       ---       **5.84 \[2.00, 17.02\]**   0.001                 
  *P* ~HWE~ \> 0.05                        12         1714/1439               76%                            \<0.001   Random    1.14 \[0.81, 1.61\]        0.45                  
  *P* ~HWE~ ≤ 0.05                         4          185/167                 82%                            0.001     Random    1.19 \[0.39, 3.64\]        0.75                  
  Heterozygote comparison (CA versus AA)   AITD       16                      2436/2287                      61%       \<0.001   Random                     1.04 \[0.83, 1.31\]   0.71
  HT                                       6          504/538                 30%                            0.21      Fixed     1.11 \[0.84, 1.47\]        0.45                  
  GD                                       12         1932/1926               67%                            \<0.001   Random    1.03 \[0.79, 1.36\]        0.81                  
  European                                 9          1468/1585               43%                            0.08      Random    1.02 \[0.82, 1.27\]        0.86                  
  Asian                                    6          904/654                 71%                            0.004     Random    0.91 \[0.56, 1.47\]        0.70                  
  African                                  1          64/48                   ---                            ---       ---       **3.02 \[1.33, 6.87\]**    0.008                 
  *P* ~HWE~ \> 0.05                        12         2152/1976               66%                            \<0.001   Random    1.06 \[0.83, 1.37\]        0.63                  
  *P* ~HWE~ ≤ 0.05                         4          284/311                 55%                            0.09      Random    0.96 \[0.53, 1.75\]        0.90                  
  Dominant model (CC + CA versus AA)       AITD       16                      3544/3117                      73%       \<0.001   Random                     1.08 \[0.84, 1.38\]   0.56
  HT                                       6          757/812                 37%                            0.16      Fixed     1.08 \[0.83, 1.40\]        0.56                  
  GD                                       12         2787/2681               78%                            \<0.001   Random    1.09 \[0.80, 1.49\]        0.57                  
  European                                 9          1884/2011               61%                            0.009     Random    1.04 \[0.81, 1.34\]        0.73                  
  Asian                                    6          1570/1051               79%                            \<0.001   Random    0.94 \[0.55, 1.60\]        0.81                  
  African                                  1          90/55                   ---                            ---       ---       **3.62 \[1.65, 7.93\]**    0.001                 
  *P* ~HWE~ \> 0.05                        12         3159/2727               75%                            \<0.001   Random    1.10 \[0.84, 1.45\]        0.50                  
  *P* ~HWE~ ≤ 0.05                         4          385/390                 71%                            0.02      Random    0.97 \[0.48, 1.96\]        0.94                  
  Recessive model (CC versus CA + AA)      AITD       16                      3544/3117                      59%       0.001     Random                     1.10 \[0.90, 1.33\]   0.36
  HT                                       6          757/812                 18%                            0.29      Fixed     0.97 \[0.77, 1.21\]        0.78                  
  GD                                       12         2787/2681               67%                            \<0.001   Random    1.13 \[0.89, 1.42\]        0.31                  
  European                                 9          1884/2011               58%                            0.02      Random    1.06 \[0.81, 1.40\]        0.65                  
  Asian                                    6          1570/1051               62%                            0.02      Random    1.06 \[0.79, 1.42\]        0.71                  
  African                                  1          90/55                   ---                            ---       ---       **2.79 \[1.12, 6.95\]**    0.03                  
  *P* ~HWE~ \> 0.05                        12         3159/2727               52%                            0.02      Random    1.06 \[0.87, 1.28\]        0.57                  
  *P* ~HWE~ ≤ 0.05                         4          385/390                 77%                            0.005     Random    1.25 \[0.58, 2.68\]        0.57                  
  Allele comparison (C versus A)           AITD       16                      3544/3117                      75%       \<0.001   Random                     1.06 \[0.91, 1.24\]   0.44
  HT                                       6          757/812                 33%                            0.19      Fixed     1.01 \[0.87, 1.17\]        0.88                  
  GD                                       12         2787/2681               81%                            \<0.001   Random    1.09 \[0.90, 1.32\]        0.37                  
  European                                 9          1884/2011               70%                            \<0.001   Random    1.04 \[0.86, 1.25\]        0.69                  
  Asian                                    6          1570/1051               78%                            \<0.001   Random    1.00 \[0.77, 1.31\]        0.98                  
  African                                  1          90/55                   ---                            ---       ---       **2.29 \[1.41, 3.73\]**    \<0.001               
  *P* ~HWE~ \> 0.05                        12         3159/2727               76%                            \<0.001   Random    1.06 \[0.90, 1.25\]        0.47                  
  *P* ~HWE~ ≤ 0.05                         4          385/390                 79%                            0.002     Random    1.04 \[0.65, 1.66\]        0.88                  

*P* ~H~: *P* value of heterogeneity test; *P~Z~*: *P* value of *Z* test.

###### 

Egger\'s test results for the publication bias of *VDR* polymorphisms and AITD risk.

  Comparison model          *P* value of Egger\'s test                   
  ------------------------- ---------------------------- ------- ------- -------
  Homozygote comparison     0.516                        0.626   0.125   0.258
  Heterozygote comparison   0.271                        0.521   0.07    0.274
  Dominant model            0.287                        0.444   0.07    0.283
  Recessive model           0.381                        0.933   0.092   0.130
  Allele comparison         0.307                        0.422   0.062   0.186

[^1]: Academic Editor: Jack Wall
